Patent submission for Optimer® binders in cosmetic products

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has filed a patent application to protect the recently developed Optimer binder sequences for novel applications in fast moving consumer goods generated as part of its partnership with Unilever.

The patent was submitted on 28 March 2024. Submission of this patent application reinforces the ongoing commercial protection of Aptamer Group’s leading technology position in the development of high-performance binders.

Aptamer Group developed the binders as part of a fee-for-service project and has continued to support Unilever in validating the functionality of the binders both in-house at Aptamer Group and within Unilever’s own labs. Submission of the patent at this stage establishes a ‘priority date’ for the binder sequences, giving Aptamer Group precedence for the protection of the intellectual property while allowing commercial negotiations to continue.

The submission of this patent is an important milestone for Aptamer Group and supports the next stages of commercial advancement with Unilever. We are really pleased with the work performed by our scientists and those at Unilever over the past few months to demonstrate the use of these Optimer binders and their suitability for application in fast moving consumer goods. We will continue to work closely with the team at Unilever to support their use of the binders in this exciting new application.” 

Dr Arron Tolley, Chief Technical Officer of Aptamer Group

Over the past 12 months we have been working with the excellent team at Aptamer Group to discover, develop and exploit their Optimer binders for cosmetic applications. We look forward to continued collaboration in this exciting applications space.”

Dr Samantha Samaras, Senior Vice President of R&D at Unilever

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Aptamer Group. (2024, April 10). Patent submission for Optimer® binders in cosmetic products. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/news/20240410/Patent-submission-for-Optimerc2ae-binders-in-cosmetic-products.aspx.

  • MLA

    Aptamer Group. "Patent submission for Optimer® binders in cosmetic products". News-Medical. 21 December 2024. <https://www.news-medical.net/news/20240410/Patent-submission-for-Optimerc2ae-binders-in-cosmetic-products.aspx>.

  • Chicago

    Aptamer Group. "Patent submission for Optimer® binders in cosmetic products". News-Medical. https://www.news-medical.net/news/20240410/Patent-submission-for-Optimerc2ae-binders-in-cosmetic-products.aspx. (accessed December 21, 2024).

  • Harvard

    Aptamer Group. 2024. Patent submission for Optimer® binders in cosmetic products. News-Medical, viewed 21 December 2024, https://www.news-medical.net/news/20240410/Patent-submission-for-Optimerc2ae-binders-in-cosmetic-products.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aptamer extends agreement with genetic medicines customer